Case Report: Janus Kinase Inhibitors and Tumor Necrosis Factor-α Inhibitors Dual Therapy Is a Potential Treatment Strategy for Difficult-To-Treat Adult-Onset Still's Disease

IF 2.4 4区医学 Q2 RHEUMATOLOGY

International Journal of Rheumatic Diseases Pub Date : 2025-05-06 DOI:10.1111/1756-185X.70237

Xiuying Lv, Xiaomei Liu, Guixiu Shi, Yan Li

引用次数: 0

查看原文本刊更多论文

病例报告：Janus激酶抑制剂和肿瘤坏死因子-α抑制剂的双重治疗是难以治疗的成人发病Still病的潜在治疗策略

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Rheumatic Diseases RHEUMATOLOGY-

CiteScore

3.70

自引率

4.00%

发文量

362

审稿时长

1 months

期刊介绍： The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.